249 related articles for article (PubMed ID: 35719954)
1. Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer.
Wu S; Pan R; Lu J; Wu X; Xie J; Tang H; Li X
Front Oncol; 2022; 12():896927. PubMed ID: 35719954
[TBL] [Abstract][Full Text] [Related]
2. An iron metabolism and immune related gene signature for the prediction of clinical outcome and molecular characteristics of triple-negative breast cancer.
Li XF; Fu WF; Zhang J; Song CG
BMC Cancer; 2022 Jun; 22(1):619. PubMed ID: 35668369
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a prognostic ferroptosis-related gene profile in acute myeloid leukaemia.
Shao R; Wang H; Liu W; Wang J; Lu S; Tang H; Lu Y
J Cell Mol Med; 2021 Dec; 25(23):10950-10960. PubMed ID: 34741393
[TBL] [Abstract][Full Text] [Related]
4. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
5. Identification of TFR2 as a novel ferroptosis‑related gene that serves an important role in prognosis and progression of triple‑negative breast cancer.
Yang Y; Du J; Huang YF; He W; Liu L; Li D; Chen R
Oncol Lett; 2024 Feb; 27(2):43. PubMed ID: 38106522
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes.
Yan C; Liu Q; Jia R
Front Oncol; 2022; 12():829045. PubMed ID: 35186763
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the ferroptosis-related
Yuan L; Liu J; Bao L; Qu H; Xiang J; Sun P
Front Oncol; 2023; 13():1032364. PubMed ID: 37064114
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and triple-negative breast cancer: Potential therapeutic targets.
Xu N; Li B; Liu Y; Yang C; Tang S; Cho WC; Huang Z
Front Oncol; 2022; 12():1017041. PubMed ID: 36568247
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
[TBL] [Abstract][Full Text] [Related]
10. A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer.
Zhang J; Zhang M; Tian Q; Yang J
Clin Exp Med; 2023 Nov; 23(7):3867-3881. PubMed ID: 37219794
[TBL] [Abstract][Full Text] [Related]
11. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
Pan J; Zhang X; Fang X; Xin Z
Front Genet; 2021; 12():739470. PubMed ID: 34497636
[TBL] [Abstract][Full Text] [Related]
12. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
Wang Y; Chen W; Zhu M; Xian L
Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526
[No Abstract] [Full Text] [Related]
16. Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma.
Da Q; Ren M; Huang L; Qu J; Yang Q; Xu J; Ma Q; Mao X; Cai Y; Zhao D; Luo J; Yan Z; Sun L; Ouyang K; Zhang X; Han Z; Liu J; Wang T
Int J Gen Med; 2022; 15():2963-2977. PubMed ID: 35313551
[TBL] [Abstract][Full Text] [Related]
17. Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer.
Chen X; Ren C; Zhou Z; Chen J; Fan X; Li X; Chen J; Zhu J
J Gene Med; 2024 Jan; 26(1):e3584. PubMed ID: 37605934
[TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
Chen Z; Wu T; Yan Z; Zhang M
Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
[TBL] [Abstract][Full Text] [Related]
19. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma.
Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Tao Y; Wang X
PeerJ; 2021; 9():e11687. PubMed ID: 34277151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
